Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs

Veterinary Immunology and Immunopathology

Volumn 66, Issue 2, 1998, Pages 113-126

  Van Rooij, E M A ^a   Haagmans, B L ^b   De Visser, Y E ^a   De Bruin, M G M ^a   Boersma, W ^a   Bianchi, A T J ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Department of Infectious Diseases and Immunology   (Netherlands)

Author keywords

DNA; Pigs; Pseudorabies virus; Vaccination

Indexed keywords

DNA VACCINE; PSEUDORABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; DRUG EFFICACY; DRUG SAFETY; IMMUNITY; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PROVOCATION TEST; PSEUDORABIES; SWINE; VACCINATION; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CLONING, MOLECULAR; COS CELLS; FEMALE; GLYCOPROTEINS; HERPESVIRUS 1, SUID; IMMUNITY, CELLULAR; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; PSEUDORABIES; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; SWINE DISEASES; VACCINATION; VACCINES, DNA; VIRAL VACCINES;

EID: 0032564473     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00186-X     Document Type: Article

References (28)

1. Bitsch V., Eskildsen M. A comparative examination of swine sera for antibody to Aujeszky virus with the conventional and modified virus-serum neutralization test and a modified complement fixation test. Acta Vet. Scand. 17:1976;142-145.
2. Bos J.D., Kapsenberg M.L. The skin immune system: Its cellular constituents and their interactions. Immunol. Today. 7:1986;235-240.
3. Brockmeier S.L., Lager K.M., Tartaglia J., Riviere M., Paoletti E., Mengeling W.L. Vaccination of pigs against pseudorabies virus with highly attenuated vaccinia (NYVAC) recombinant viruses. Vet. Microbiol. 38:1993;41-58.
4. Casares S., Inaba K., Brumeanu T., Steinman R., Bona C. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186:1997;1481-1486.
5. Christensen L.S., Medveczky I., Starnbygaard B.S., Pejsak Z. Characterization of field isolates of suid herpesvirus I (Aujeszky's disease virus) as derivatives of attenuated vaccine strains. Arch. Virol. 124:1992;225-234.
6. Coney L., Wang B., Ugen K.E., Boyer J., McCallus D., Srikantan V., Agadjanyan M., Pachuk C.J., Herold K., Merva M., Gilbert L., Deng K., Moelling K., Newman M., Williams W.V., Weiner D.B. Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine. 12:1994;1545-1550.
7. Danko I., Fritz J.D., Jiao S., Hogan K., Latendresse J.S., Wolff J.A. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Therapy. 1(2):1994;114-121.
8. Donnelly J.J., Ulmer J.B., Liu M.A. Immunization with DNA. J. Immunol. Methods. 176:1994;145-152.
9. Drunen van Littel-van den Hurket S., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., McCartney D., Watts T., Babiuk L.A. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79:1998;831-839.
10. Eliot M., Fargeaud D., L'Haridon R., Toma B. Identification of pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Arch. Virol. 99:1988;45-56.
11. Fu T., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., Liu X., Donelly J.J., Liu M.A. Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen-presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3(6):1997;362-371.
12. Gerdts V., Jöns A., Makoschy B., Visser N., Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J. Gen. Virol. 78:1997;2139-2146.
13. Haagmans, B.L., Van Rooij, E.M.A., Dubelaar, M., Kimman, T.G., Horzinek, M.C., Schijns, V.E.C.J., Bianchi, A.T.J., Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D, Vaccine, in press.
14. Henderson L.M., Katz J.B., Erickson G.M., Mayfield J.E. In vivo and in vitro genetic recombination between conventional and gene-deleted vaccine strains of pseudorabies virus. Am. J. Vet. Res. 51:1990;1656-1662.
15. Inchauspe G., Vitvitski L., Major M.E., Jung G., Sprengler U., Maisonnas M., Trepo C. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: Comparative studies of antibody and T-helper responses following genetic immunization. DNA and Cell Biology. 16(2):1997;185-195.
16. Iwasaki A., Torres C., Ohashi P., Robinson H., Barber B.H. The dominant role of bone-marrow derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159(1):1997;11-14.
17. Kimman T.G., Brouwers R.A.M., Daus F.J., Van Oirschot J.T., van Zaane D. Measurement of isotype-specific antibody responses to Aujeszky's disease virus in sera and mucosal secretions of pigs. Vet. Immunol. Immunopathol. 31:1992;95-113.
18. Kimman T.G., De Bruin T.M.G., Voermans J.J.M., Peeters B.P.H., Bianchi A.T.J. Development and antigen specificity of the lymphoproliferation response to pseudorabies virus: Dichotomy between secondary B- and T-cell responses. Immunol. 86:1995;372-378.
19. Kimman T.G., De Bruin T.M.G., Voermans J.J.M., Bianchi A.T.J. Cell mediated immunity to pseudorabies virus: Cytolytic effector cells with characteristics of lymphokine-activated killer cells lyse virus-infected and glycoprotein gB- and gC-transfected L14 cells. J. Gen. Virol. 77:1996;987-990.
20. Marchioli C.C., Yancey R.J., Petrovskis E.A., Timmins J.G., Post L.E. Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: Expression by vaccinia virus and Chinese hamster ovary cells. J. Virol. 61:1987;3977-3982.
21. MacFerran J.B., Dow C. Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus. Res. Vet. Sci. 19:1975;17-22.
22. Mengeling W.L., Brockmeier S.L., Lager K.M. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII and gIII as a PR vaccine for pigs. Arch. Virol. 134:1994;259-269.
23. Moormann R.J.M., De Rover T., Briaire J., Peeters B.P.H., Gielkens A.L.J., Van Oirschot J.T. Inactivation of the thymidine kinase of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J. Gen. Virol. 71:1990;1591-1595.
24. Riviere M., Tartaglia J., Perkus M.E., Norton E.K., Molnar Bongermino C.M., Lacoste F., Duret C., Desmettre P., Paoletti E. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J. Virol. 66(6):1992;3424-3434.
25. Schrijver R.S., Langedijk J.P.M., Keil G.M., Middel W.G.J., Maris-Veldhuis M., Van Oirschot J.T., Rijsewijk F.A.M. Comparison of DNA application methods to reduce BRSV shedding in cattle. Vaccine. 16:1998;130-134.
26. Stellman C., Vannier P., Chappuis G., Brun A., Dauvergne M., Fargeaud D., Bugand M., Colson X. The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. J. Biol. Standard. 17:1989;17-27.
27. Van Oirschot J.T., Gielkens A.L.J., Moormann R.J.M., Berns A.J.M. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. Vet. Microbiol. 23:1990;85-101.
28. Zuckermann F.A., Zsak L., Mettenleiter T.C., Ben-Porat T. Pseudorabies virus glycoprotein gIII is a major target for murine and swine virus-specific cytotoxic T lymphocytes. J. Virol. 64:1990;802-812.